S-100 and NSE as Serum Markers in Melanoma

References

• Paus E, Nustad K. Immunoradiometric assay for αγ and γγ-enolase (neuron-specific enolase) with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem 1989; 35: 2034–8
   PubMed Web of Science ®Google Scholar
• Wibe E, Paus E, Aamdal S. Neuron-specific enolase (NSE) in serum of patients with malignant melanoma. Cancer Lett 1990; 52: 29–31
   PubMed Web of Science ®Google Scholar
• Fagnart O C, Sindic C JM, Laterre C. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 38: 1387–91
   Google Scholar
• Cooper E K. Neuron-specific enolase. Int J Biol Markers 1994; 9: 205–10
   PubMedGoogle Scholar
• Schmechel D, Marangos P M, Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834–6
   PubMed Web of Science ®Google Scholar
• Schaarschmidt H, Prange H W, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease. Stroke 1994; 24: 558–65
   Google Scholar
• Skogseid I M, Nordby H K, Urdal P, Paus E, Lilleaas F. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir 1992; 115: 106–11
   PubMed Web of Science ®Google Scholar
• Isobe T, Ishioka N, Okuyama T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100a protein. Eur J Biochem 1981; 115: 469–74
   PubMedGoogle Scholar
• Ludwin S K, Kosek J C, Eng L F. The topographic distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J Comp Neurol 1976; 165: 197–208
   PubMedGoogle Scholar
• Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991; 12: 713–26
   PubMed Web of Science ®Google Scholar
• Albert K A, Wu WC-S, Naim A C, Greengard P. Inhibition by calmodulin of calcium/phospholipid dependent protein phosphorylation. Proc Natl Acad Sci USA 1984; 81: 3622–5
   PubMedGoogle Scholar
• Endo T, Hidaka H. Effects of S-100 protein on microtubule assembly-disassembly. FEBS Lett 1983; 161: 235–8
   PubMedGoogle Scholar
• Shashoua V E, Hesse G W, Moore B W. Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J Neurochem 1984; 42: 1536–41
   PubMed Web of Science ®Google Scholar
• Whitaker-Azmitia P M, Murphy R, Azmitia E C. Stimulation of astroglial 5-HT receptor releases the serotoninergic growth factor, protein S-100 and alters astroglial morphology. Brain Res 1990; 528: 155–8
   PubMedGoogle Scholar
• Selinfreund R H, Barger S W, Pledger W J, Van Eldik I J. Neurotrophic protein S-100β stimulates glial cell proliferation. Proc Natl Acad Sci USA 1991; 88: 3554–8
   PubMed Web of Science ®Google Scholar
• Cocchia D, Michetti F, Donato R. Immunohistochemical and immunocytochemical localization of S-100 antigen in normal human skin. Nature 1981; 294: 85–7
   PubMed Web of Science ®Google Scholar
• Gaynor R, Irie R, Morton D, Herschman H R. S-100 protein is present in cultured human malignant melanoma. Nature 1980; 286: 400–1
   PubMedGoogle Scholar
• Pfeiffer S E, Kornblith P L, Cares H L, Seals J, Levine L. S-100 protein in human acoustic neurinomas. Brain Res 1972; 41: 187–93
   PubMedGoogle Scholar
• Egan M, Crocher J, Newman J, Collard M. Immunohistochemical localization of S-100 protein in skin tumours. Arch Pathol Lab Med 1986; 110: 765–7
   PubMedGoogle Scholar
• Van Eldik L J, Jensen R A, Ehrenfried B A, Whetsell W O. Immunohistochemical localization of S-100β in human nervous system tumors by using monoclonal antibodies with specificity for the S-100β polypeptide. J Histochem Cytochem 1986; 34: 977–82
   PubMedGoogle Scholar
• Persson L, Hardemark H G, Gustafsson J, et al. S100 protein and neuron-specific enolase in cerebro-spinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911–8
   PubMed Web of Science ®Google Scholar
• Sindic C, Chalon M, Cambiaso C, Laterre E, Masson P. Assessment of damage to the central nervous system by determination of S100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982; 45: 1130–5
   PubMed Web of Science ®Google Scholar
• Johnsson P, Lundqvist C, Lindgren A, Ferenez I, Alling C, Stahl E. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth 1995; 9: 1–6
   Google Scholar
• Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value. J Neurol Neurosurg Psychiatry 1995; 59: 103–4
   PubMed Web of Science ®Google Scholar
• Wibe E, Hannisdal E, Paus E, Aamdal S. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma. Eur J Cancer 1992; 28: 1692–5
   Google Scholar
• Hau Bei Gou, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmuller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 1995; 31: 924–8
   Google Scholar
• American Joint Committee on Cancer. Manual for Staging of Cancer, 3rd edition. JB Lippincott, Philadelphia 1988; 143–8
   Google Scholar